---
document_datetime: 2025-12-12 13:52:49
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/imaavy-epar-all-authorised-presentations_en.pdf
document_name: imaavy-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7414919
conversion_datetime: 2025-12-17 14:25:12.503098
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|------------|---------------------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/25/1989/001 | Imaavy            | 185 mg/mL  | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 1.62 mL                   | 1 vial      |
| EU/1/25/1989/002 | Imaavy            | 185 mg/mL  | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 6.5 mL                    | 1 vial      |